The Lewy Body Dementia Domain Rating Scale: an update
After consensus on the conceptual framework and preliminary content is established, the authors will consult with a broader range of stakeholders, including people living with LBD and their care partners, will be required to further develop LBD-DRS. Engagement with regulatory bodies and the pharmaceutical industry will guide further development before validation studies are pursued.
Authors
- John Kane
- Federico Rodríguez‐Porcel (ORCID: https://orcid.org/0000-0002-7492-5095)
- John‐Paul Taylor (ORCID: https://orcid.org/0000-0001-7958-6558)
- Elie Matar
- Brad F Boeve
- The Lewy Body Dementia Domain Rating Scale steering group
Institutions
- Queen's University Belfast (GB)
- Mayo Clinic (US)
- Medical University of South Carolina (US)
- WinnMed (US)
- MIND Research Institute (US)
- Newcastle University (GB)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_102206
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00